Top and Current
Source: (remove) : Kyle Rose
RSSJSONXMLCSV
Top and Current
Source: (remove) : Kyle Rose
RSSJSONXMLCSV
Wed, January 31, 2024
Fri, August 4, 2023
Tue, May 2, 2023
Tue, March 28, 2023
Wed, February 1, 2023
Wed, November 9, 2022
Tue, November 1, 2022
Mon, May 9, 2022
Tue, February 8, 2022
Wed, August 4, 2021
Wed, July 28, 2021
Thu, May 6, 2021
Wed, May 5, 2021
Fri, April 30, 2021
Wed, April 28, 2021
Mon, March 8, 2021
Tue, February 23, 2021
Fri, October 30, 2020
Thu, October 8, 2020
Tue, May 12, 2020
Thu, May 7, 2020
Thu, November 7, 2019
Wed, October 30, 2019
Wed, September 18, 2019
Wed, August 28, 2019
Fri, July 26, 2019
Thu, April 25, 2019
Wed, April 24, 2019
Mon, July 30, 2018
Fri, April 27, 2018
Fri, October 27, 2017
Wed, October 11, 2017
Thu, August 24, 2017
Fri, July 28, 2017
Fri, July 24, 2015
Fri, October 17, 2014
Mon, May 19, 2014
Thu, April 24, 2014
Thu, July 19, 2012

Kyle Rose Upgraded (SYK) to Strong Buy and Held Target at $360 on, Jan 31st, 2024


Published on 2024-10-28 08:39:59 - WOPRAI, Kyle Rose
  Print publication without navigation


Kyle Rose of Canaccord Genuity, Upgraded "Stryker Corporation" (SYK) to Strong Buy and Held Target at $360 on, Jan 31st, 2024.

Kyle has made no other calls on SYK in the last 4 months.



There are 2 other peers that have a rating on SYK. Out of the 2 peers that are also analyzing SYK, all agree with Kyle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Drew Ranieri of "Morgan Stanley" Maintained at Hold with Increased Target to $320 on, Monday, December 4th, 2023
  • Danielle Antalffy of "UBS" Maintained at Hold with Increased Target to $297 on, Thursday, November 9th, 2023